Abstract:
PURPOSE: A therapeutic composition is provided to be able to be effectively used in prevention, alleviation or treatment of kidney diseases as the Panax species plant extract or the product of the Maillard type browning reaction with glucose amino acid have an excellent removal ability of active oxygen, and remarkably excellent activation to suppress damage of kidney epithelial cell due to the oxidative stress. CONSTITUTION: A pharmaceutical composition for prevention or treatment of kidney diseases comprises ginsenoside Re, Panax species plant extract including ginsenoside Re, or the product of the Maillard browning reaction obtained by reacting ginsenoside-originated saccharide with amino acid at 100-130deg.C, as an active ingredient. A composition for health functional food for prevention or alleviation of kidney diseases includes ginsenoside Re, Panax species plant extract including ginsenoside Re, or the product of the Maillard browning reaction obtained by reacting ginsenoside-originated saccharide with amino acid at 100-130deg.C, as an active ingredient. The Panax species plant is Korean ginseng, Panax quinquefolius, Panax notoginseng, Japanse seng, Panax trifolium, Himalayan ginseng, Panax vietnamensis, their cultured root, or their combination. [Reference numerals] (AA) Ginsenoside Re; (BB) Ginsenoside Rg_2; (CC) Dehydration reaction; (DD) Ginsenoside Rg_6; (EE) Ginsenoside F_4; (FF) Separated glucose + Glycine; (GG) Maillard browning reaction
Abstract:
A composition containing Chamaenerion angustifolium extract with anti-wrinkle and antioxidant activities is provided to show wrinkle and elasticity improvement by the Chamaenerion angustifolium extracts having effects of inhibiting type I collagenase and AP-1. A composition containing Chamaenerion angustifolium extract with anti-wrinkle and antioxidant activities comprises Chamaenerion angustifolium extract obtained by adding water and alcohol or a mixed solvent thereof. The Chamaenerion angustifolium extract inhibits inflammation and improves skin elasticity. The composition has a formulation of external skin application. The composition represents cosmetics or health foods. The Chamaenerion angustifolium extract is an active ingredient in the composition.
Abstract:
A composition containing Ortilia secunda extracts is provided to show wrinkle and elasticity improvement by the Ortilia secunda extracts having effects of inhibiting type I collagenase and AP-1 and increasing generation of collagen while suppressing decomposition of the collagen. A composition for wrinkle improvement comprises Ortilia secunda extracts obtained by adding water and C1-C4 low alcohol such as ethanol and methanol or mixed solvents thereof. The Ortilia secunda extracts are active ingredients in the composition for wrinkle improvement. The Ortilia secunda extracts eliminate radicals. The composition has a formulation of external skin application. The composition for wrinkle improvement represents antioxidant.
Abstract:
본 발명은 족제비싸리 추출물을 유효성분으로 포함하여 신장 질환을 예방하거나 치료하는 조성물에 관한 것이다. 본 발명에 따른 조성물은 자연으로부터 얻어진 천연물을 유효성분으로 포함하여 인체에 적용시 부작용이 적을 뿐 아니라, 장기간 사용으로 인한 내성이 생길 가능성이 낮다. 특히, 본 발명의 조성물은 신장 세포의 보호에 있어서, 우수한 효능을 가지므로, 신장 질환의 예방 또는 치료에 있어서 유용하게 사용될 수 있다.
Abstract:
본 발명은 진세노사이드 Re, 진세노사이드 Re를 포함하는 파낙스속 식물 추출물, 또는 글루코스를 아미노산과 함께 100 ~ 130℃에서 0.5 ~ 12 시간 반응시켜 얻어진 마이얄형 갈색화 반응 생성물을 유효성분으로 포함하는 신장질환의 예방, 개선 또는 치료용 조성물을 제공한다.
Abstract:
The present invention relates to a composition for anti-aging or moisturizing containing a sargassum yezoense extract. The composition for anti-aging or moisturization includes a sargassum yezoense extract as an active ingredient. The compositions of the present invention has improved anti-aging and moisturizing performance. [Reference numerals] (AA) Untreated group WY
Abstract:
The present invention provides a composition containing esculin, an esculin derivative, or a pharmaceutically acceptable salt or a solvate thereof as an active ingredient for reducing blood glucose. The present invention provides esculin, an esculin derivative, or a pharmaceutically acceptable salt or solvate thereof as an active ingredient for reducing creatinine in blood.